Our team presented new meta-analysis at #ISCTM showing that more frequent clinician‑administered assessments have a strong association with magnitude of placebo response in #GAD trials – consistent with findings from our #MDD meta‑analysis. bit.ly/4ru1EL1

It's officially fall and Kernel is on the move! First stop: Amsterdam for the #ISCTM Autumn Conference.

You can find our CEO, Ryan Field, at the poster session & reception on Oct. 10 from 6:00 - 7:30 p.m. presenting our latest work on #depression severity monitoring in #clinicaltrials.

Our team was at #ISCTM to present a meta-analysis exploring the impact of clinical trial design factors on placebo effect in #MDD trials. Key finding links number & frequency of clinician-administered assessments to increased placebo response. Read more: bit.ly/3Qsz8bx

Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025